Literature DB >> 24102778

Prevalence and epidemiological characteristics of vaginal candidiasis in the UAE.

Mawieh Hamad1, Norair Kazandji, Samir Awadallah, Hilda Allam.   

Abstract

Vaginal candidiasis (VC) continues to be a health problem to women worldwide. Although the majority of VC cases are caused by Candida albicans (C. albicans), non-albicans Candida spp. like C. glabrata and C. tropicalis are emerging as important and potentially resistant opportunistic agents of VC. The objective of this study was to evaluate the prevalence and epidemiology of VC in the UAE through retrospective analysis of pertinent data compiled by the microbiology and infection control unit at Latifa Hospital, Dubai between 2005 and 2011. The incidence of VC significantly increased from 10.76% in 2005 to 17.61% in 2011; average prevalence was 13.88%. C. albicans occurred at a frequency of 83.02%, C. glabrata at 16.5% and C. tropicalis at 1.2%. A single C. dubliniensis isolate was identified in the sample population. The percentage of C. albicans significantly decreased from 83.02% in the sample population as a whole to 60.8% in subjects over 45 years of age (P < 0.01) and that of C. glabrata, C. tropicalis and C. krusei significantly increased from 13.88%, 0.9% and 0.03% to 29.7%, 6.7% and 1.4% (P < 0.05) respectively. The incidence of VC in the UAE is on the rise and the frequency of non-albicans Candida spp. is noticeably increasing especially in postmenopausal women.
© 2013 Blackwell Verlag GmbH.

Entities:  

Keywords:  C. albicans; C. dubliniensis; C. glabrata; UAE; epidemiology; vaginal candidiasis

Mesh:

Year:  2013        PMID: 24102778     DOI: 10.1111/myc.12141

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  10 in total

1.  Effect of norfloxacin therapy for acute, uncomplicated lower urinary tract infection on vaginal Candida prevalence.

Authors:  Rodrigo M Rocha; Pâmela C M Delvas Zanni; Patrícia de Souza Bonfim-Mendonça; Fabrícia Gimenes; Silvia S Dantas Alczuk; Terezinha I Estivalet Svidzinski; Márcia E Lopes Consolaro
Journal:  Int Urogynecol J       Date:  2015-11-13       Impact factor: 2.894

2.  Comparative Analysis of the Capacity of the Candida Species To Elicit Vaginal Immunopathology.

Authors:  Hubertine M E Willems; David J Lowes; Katherine S Barker; Glen E Palmer; Brian M Peters
Journal:  Infect Immun       Date:  2018-11-20       Impact factor: 3.441

3.  Prevalence, species distribution and antifungal susceptibility of Candida albicans causing vaginal discharge among symptomatic non-pregnant women of reproductive age at a tertiary care hospital, Vietnam.

Authors:  Do Ngoc Anh; Dao Nguyen Hung; Tran Viet Tien; Vu Nhat Dinh; Vu Tung Son; Nguyen Viet Luong; Nguyen Thi Van; Nguyen Thi Nhu Quynh; Nguyen Van Tuan; Le Quoc Tuan; Nguyen Duy Bac; Nguyen Khac Luc; Le Tran Anh; Do Minh Trung
Journal:  BMC Infect Dis       Date:  2021-06-03       Impact factor: 3.090

4.  Species Distribution and In Vitro Antifungal Susceptibility of Vulvovaginal Candida Isolates in China.

Authors:  Feng-Juan Wang; Dai Zhang; Zhao-Hui Liu; Wen-Xiang Wu; Hui-Hui Bai; Han-Yu Dong
Journal:  Chin Med J (Engl)       Date:  2016-05-20       Impact factor: 2.628

5.  Virulence factors and genetic variability of vaginal Candida albicans isolates from HIV-infected women in the post-highly active antiretroviral era.

Authors:  Pâmela Cristina Mastellaro Delvas Zanni; Patrícia de Souza Bonfim-Mendonça; Melyssa Negri; Sandra Sayuri Nakamura; Lucélia Donatti; Terezinha Inez Estivalet Svidzinski; Márcia Edilaine Lopes Consolaro
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2017-08-03       Impact factor: 1.846

6.  Risk Factors of Vulvovaginal Candidiasis among Women of Reproductive Age in Xi'an: A Cross-Sectional Study.

Authors:  Xianling Zeng; Yafei Zhang; Taohong Zhang; Yan Xue; Huiqiu Xu; Ruifang An
Journal:  Biomed Res Int       Date:  2018-06-07       Impact factor: 3.411

7.  Emergence of Vulvovaginal Candidiasis among Lebanese Pregnant Women: Prevalence, Risk Factors, and Species Distribution.

Authors:  Nahed Ghaddar; Ali El Roz; Ghassan Ghssein; José-Noel Ibrahim
Journal:  Infect Dis Obstet Gynecol       Date:  2019-07-28

Review 8.  Vulvovaginal Candidiasis: A Current Understanding and Burning Questions.

Authors:  Hubertine M E Willems; Salman S Ahmed; Junyan Liu; Zhenbo Xu; Brian M Peters
Journal:  J Fungi (Basel)       Date:  2020-02-25

9.  Divergent EGFR/MAPK-Mediated Immune Responses to Clinical Candida Pathogens in Vulvovaginal Candidiasis.

Authors:  Jingyun Zhang; Jingwen Peng; Dongmei Li; Huan Mei; Yu Yu; Xiaofang Li; Xiaodong She; Weida Liu
Journal:  Front Immunol       Date:  2022-05-26       Impact factor: 8.786

Review 10.  Plants' Natural Products as Alternative Promising Anti-Candida Drugs.

Authors:  Sameh Soliman; Dina Alnajdy; Ali A El-Keblawy; Kareem A Mosa; Ghalia Khoder; Ayman M Noreddin
Journal:  Pharmacogn Rev       Date:  2017 Jul-Dec
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.